Garden Grove

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Schizophrenia3 trials
• Bipolar disorder1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Recruiting1 trial

Lead sponsor

• Intra-Cellular Therapies, Inc.2 trials
• MapLight Therapeutics2 trials

Running trials

• Recruiting

  A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  NCT07459647· Phase 2· MapLight Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

  NCT07038876· Phase 2· MapLight Therapeutics· Source

• Completed

  Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

  NCT06462586· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

  NCT04959032· Phase 3· Intra-Cellular Therapies, Inc.· Source